Skip to Main Content

Author Details

David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
1993
132
40
PMIDPaper TitleJournal TitlePublished Year
37506981Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.Int J Radiat Oncol Biol Phys2024
36910642The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases.Front Oncol2023
37684373Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.Commun Med (Lond)2023
37190312First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.Cancers (Basel)2023
37188783Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nat Med2023
37341842<sup>18</sup>F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.J Neurooncol2023
37296975Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study.Cancers (Basel)2023
36521103Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.J Clin Oncol2023
35064450Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.J Neurooncol2022
35846050Primary central nervous system lymphoma: Inter-compartmental progression.EJHaem2022
35371526Patients with brain metastasis and the risk of falls: a plausibly preventable entity.Neurooncol Pract2022
35667529Sex-Specific Differences in Low-Grade Glioma Presentation and Outcome.Int J Radiat Oncol Biol Phys2022
35819008First clinical experience with belzutifan in von Hippel-Lindau disease associated CNS hemangioblastoma.CNS Oncol2022
35486307Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas.J Neurooncol2022
36612116Novel Therapeutic Approaches in Neoplastic Meningitis.Cancers (Basel)2022
33027815A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.Neurosurgery2021
33762182Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management.Surv Ophthalmol2021
33604574Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.Neurooncol Adv2021
32166308A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.Neuro Oncol2020
32026432Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.J Neurooncol2020
31676312Large B-cell lymphoma of the uvea: Histopathologic variants and clinicopathologic correlation.Surv Ophthalmol2020
32625208Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.Front Immunol2020
32923886Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent Glioblastoma.JCO Precis Oncol2020
32506123Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.Neuro Oncol2020
32442298Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.Blood Adv2020
31022510Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.Int J Radiat Oncol Biol Phys2019
31320597A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.Clin Cancer Res2019
31292802Phase II study of Dovitinib in recurrent glioblastoma.J Neurooncol2019
31461674Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.Int J Radiat Oncol Biol Phys2019
31600167Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.JCI Insight2019
30738402Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.J Neurosurg2019
30796838The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis.Neuro Oncol2019
28973311Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.Neurosurgery2018
29485076Risk Factors for Malignant Transformation of Low-Grade Glioma.Int J Radiat Oncol Biol Phys2018
29652233First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.J Neurosurg2018
29304358Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.Lancet Oncol2018
28039365Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.Neuro Oncol2017
28434110The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.J Neurooncol2017
28192598Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.Cancer2017
28453751The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.Neuro Oncol2017
28666902Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.Pract Radiat Oncol2017
27663390Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma.Neuro Oncol2017
27225542Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update.Curr Treat Options Neurol2016
31386010Intracranial hemorrhage in setting of glioblastoma with venous thromboembolism.Neurooncol Pract2016
27456950A cure is possible: a study of 10-year survivors of brain metastases.J Neurooncol2016
23799286Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.Am J Clin Oncol2015
26245136Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.J Neurooncol2015
26285766Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.J Neurooncol2015
26308485Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.Cancer2015
26088460Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.J Neurooncol2015
  • 1 - 50 of 132

Recommended Authors

Malaka Ameratunga
Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 1
Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 2
Josef Pichler
Kepler University Hospital
Career Start Year 2006
Number of shared co-authors 6
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 24
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 6
Hussein A Tawbi
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 9
Matthias Preusser
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 15
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 4
W K Alfred Yung
The University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 7
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 1
Wendy Seiferheld
Career Start Year 1999
Number of shared co-authors 4
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 16
Sunil Sharma
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 1
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1997
Number of shared co-authors 14
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 9
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 4
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 28
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 10
Ho-Shin Gwak
National Cancer Center
Career Start Year 1994
Number of shared co-authors 2
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 13
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 0
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 3
Christine Marosi
Medical University of Vienna
Career Start Year 1987
Number of shared co-authors 3
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 28
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 6
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 17
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 12
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 11
John P Kirkpatrick
Duke University Medical Center
Career Start Year 1978
Number of shared co-authors 4
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

John H Suh
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 33
Gene H Barnett
Co-authored papers 28
Michael A Vogelbaum
Moffit Cancer Center
Co-authored papers 24
Tracy T Batchelor
Brigham and Women's Hospital
Co-authored papers 8
Patrick Y Wen
Co-authored papers 7
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers 7
Minesh P Mehta
Co-authored papers 6
Chandana A Reddy
Cleveland Clinic
Co-authored papers 5
Quentin R Smith
School of Pharmacy, Texas Tech University Health Sciences Center
Co-authored papers 5
Eric A Klein
Cleveland Clinic
Co-authored papers 5
Cathy Brewer
Co-authored papers 5
Robert J Weil
Rhode Island Hospital
Co-authored papers 4
Bruce H Cohen
Akron Children's Hospital
Co-authored papers 4
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 4
Scott H Kaufmann
Mayo Clinic
Co-authored papers 4
Susan M Staugaitis
Co-authored papers 3
David Schiff
University of Virginia School of Medicine
Co-authored papers 3
Jann N Sarkaria
Co-authored papers 2
Caterina Giannini
Mayo Clinic
Co-authored papers 2
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Paul G Fisher
Stanford University
Co-authored papers 2
Andrew S Chi
Co-authored papers 2
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
Paul R Lockman
Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University
Co-authored papers 2
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Co-authored papers 2
Morris D Groves
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 2
Nancy U Lin
Co-authored papers 2
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Roger Stupp
Northwestern University
Co-authored papers 2
Release 1.2